ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 534,65
0,19%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA Teva Pharmaceutical Industries Ltd

13,89
0,64 (4,83%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Teva Pharmaceutical Industries Ltd TEVA NYSE Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,64 4,83% 13,89 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
13,31 13,31 13,98 13,81 13,25
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/4/202423:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/4/202423:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/4/202414:00BWTeva’s New Real-World Evidence Presented at the 2024 AAN..
11/4/202414:30BWTeva Confirms Efficacy and Safety of AJOVY® (fremanezumab)..
09/4/202422:30BWTeva to Host Conference Call to Discuss First Quarter 2024..
06/4/202419:00BWNew Pharmacokinetic Modeling Data Presented by Teva..
04/4/202414:30BWTeva and mAbxience Announce Strategic Global Licensing..
01/4/202414:30BWClinical Collaboration Agreement between Teva and Launch..
07/3/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/3/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202413:00BWTeva and Jiangsu Nhwa Forge Strategic Partnership to Promote..
24/2/202402:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
24/2/202402:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
20/2/202414:30BWTeva Presents New Data Supporting Safety, Tolerability and..
13/2/202415:05IHMARKETNEWSHotter-Than-Expected Inflation Data Likely To Weigh On Wall..
12/2/202423:03IHMARKETNEWSDow Reaches New Record Closing High But Nasdaq, S&P 500 Give..
12/2/202415:13IHMARKETNEWSTeva Pharmaceutical, Urban Outfitters Upgraded
01/2/202413:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202413:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202413:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202413:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202413:00EDGAR2Form 8-K - Current report
31/1/202413:00BWTeva Reports Growth in Fourth Quarter and Full Year 2023
31/1/202412:00BWTeva Announces Intention to Divest API Business as Part of..
02/1/202422:30BWTeva to Host Conference Call to Discuss Fourth Quarter and..
02/1/202414:50DJNCorcept Therapeutics Shares Slide Premarket on Loss in Teva..
28/12/202322:30BWTeva to Present at the 42nd Annual J.P. Morgan Healthcare..
14/12/202314:30BWTeva and Biolojic Design Announce Exclusive License..

Dernières Valeurs Consultées

NYSE
TEVA
Teva Pharmaceutical Indu...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés